Hypertension and Alzheimer disease: Another brick in the wall of awareness

Hypertension

Volumn 65, Issue 1, 2015, Pages 36-38

  Thorin, Eric ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA SECRETASE; PRESENILIN 1; RNA; VASCULOTROPIN A;

ALZHEIMER DISEASE; AUTOSOMAL DOMINANT INHERITANCE; CARDIOVASCULAR DISEASE; DEPRESSION; DYSLIPIDEMIA; GENE MUTATION; HUMAN; HYPERTENSION; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PHYSICAL INACTIVITY; ANIMAL; COMPLICATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS;

ALZHEIMER DISEASE; ANIMALS; FEMALE; GENE EXPRESSION REGULATION; HYPERTENSION; RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84919424396     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04257     Document Type: Note

References (12)

1. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimers disease: an analysis of population-based data. Lancet Neurol. 2014;13:788-794.
2. Marr RA, Hafez DM. Amyloid-beta and Alzheimers disease: the role of neprilysin-2 in amyloid-beta clearance. Front Aging Neurosci. 2014;6:187.
3. Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol. 2011;37:56-74.
4. Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension. 2013;62:810-817.
5. Aanerud J, Borghammer P, Chakravarty MM, Vang K, Rodell AB, Jónsdottir KY, Møller A, Ashkanian M, Vafaee MS, Iversen P, Johannsen P, Gjedde A. Brain energy metabolism and blood flow differences in healthy aging. J Cereb Blood Flow Metab. 2012;32:1177-1187.
6. de la Torre JC. Cerebral hemodynamics and vascular risk factors: setting the stage for alzheimers disease. JAD. 2012;32:553-567.
7. Cifuentes D, Poittevin M, Dere E, Broquères-You D, Bonnin P, Benessian J, Pocard M, Mariani J, Kubis N, Merkulova-Rainon T, Lévy BI. Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease. Hypertension. 2015;65:218-224.
8. Radde R, Bolmont T, Kaeser SA, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Reports. 2006;7:940-946.
9. Durand MJ, Gutterman DD. Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirculation. 2013;20:239-247.
10. Chow N, Bell RD, Deane R, Streb JW, Chen J, Brooks A, Van Nostrand W, Miano JM, Zlokovic BV. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in alzheimers phenotype. Proc Natl Acad Sci U S A. 2007;104:823-828.
11. ORourke MF, Safar ME, Dzau V. The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med. 2010;15:461-468.
12. Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. N Engl J Med. 2013;369:2275-2277